c="glycogen-storage disease type II" 1:19 1:22||t="problem"||cui="C0017921"||tot="Glycogen storage disease type II"||ns="-1000"
c="Glycogen-storage disease type II (GSDII" 2:0 2:4||t="problem"||cui="C0017921"||tot="Glycogen storage disease type II"||ns="-1000"
c="GSDII" 2:35 2:35||t="problem"||cui="C0017921"||tot="Glycogen storage disease type II"||ns="-1000"
c="Sequence analysis" 2:66 2:67||t="test"||cui="C0162801"||tot="Sequence Analysis"||ns="-1000"
c="Val-816" 2:77 2:77||t="medication"||cui="C0042285"||tot="Valine"||ns="-861"
c="Thr-927" 2:80 2:80||t="medication"||cui="C0040005"||tot="Threonine"||ns="-861"
c="Val-816" 2:142 2:142||t="medication"||cui="C0042285"||tot="Valine"||ns="-861"
c="Thr-927" 2:176 2:176||t="medication"||cui="C0040005"||tot="Threonine"||ns="-861"
c="Ile substitution deleting one" 2:176 2:179||t="medication"||cui="C0205447"||tot="One"||ns="-812"
